The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Myositis


Psychiatry related information on Myositis


High impact information on Myositis


Chemical compound and disease context of Myositis


Biological context of Myositis


Anatomical context of Myositis


Gene context of Myositis


Analytical, diagnostic and therapeutic context of Myositis


  1. Mitochondrial myopathy caused by long-term zidovudine therapy. Dalakas, M.C., Illa, I., Pezeshkpour, G.H., Laukaitis, J.P., Cohen, B., Griffin, J.L. N. Engl. J. Med. (1990) [Pubmed]
  2. Reversible renal failure and myositis caused by phenytoin hypersensitivity. Michael, J.R., Mitch, W.E. JAMA (1976) [Pubmed]
  3. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. Bunn, C.C., Bernstein, R.M., Mathews, M.B. J. Exp. Med. (1986) [Pubmed]
  4. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Appleyard, S.T., Dunn, M.J., Dubowitz, V., Rose, M.L. Lancet (1985) [Pubmed]
  5. The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. Dicker, R.M., James, N., Cunha, B.A. Ann. Intern. Med. (1990) [Pubmed]
  6. Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice. Askanas, V., Engel, W.K. Am. J. Pathol. (1998) [Pubmed]
  7. Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseases. Watts, R.A., Ravirajan, C.T., Wilkinson, L.S., Williams, W., Griffiths, M., Butcher, D., Horsfall, A.T., Staines, N.A., Isenberg, D.A. Clin. Exp. Immunol. (1991) [Pubmed]
  8. Pravastatin-associated inflammatory myopathy. Schalke, B.B., Schmidt, B., Toyka, K., Hartung, H.P. N. Engl. J. Med. (1992) [Pubmed]
  9. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Mathews, M.B., Bernstein, R.M. Nature (1983) [Pubmed]
  10. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. Casciola-Rosen, L., Nagaraju, K., Plotz, P., Wang, K., Levine, S., Gabrielson, E., Corse, A., Rosen, A. J. Exp. Med. (2005) [Pubmed]
  11. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. Feist, E., Dörner, T., Kuckelkorn, U., Schmidtke, G., Micheel, B., Hiepe, F., Burmester, G.R., Kloetzel, P.M. J. Exp. Med. (1996) [Pubmed]
  12. Myositis with tretinoin. Miranda, N., Oliveira, P., Frade, M.J., Melo, J., Marques, M.S., Parreira, A. Lancet (1994) [Pubmed]
  13. Myositis in association with carbimazole therapy. Page, S.R., Nussey, S.S. Lancet (1989) [Pubmed]
  14. Inclusion body myositis: clinical and pathological boundaries. Amato, A.A., Gronseth, G.S., Jackson, C.E., Wolfe, G.I., Katz, J.S., Bryan, W.W., Barohn, R.J. Ann. Neurol. (1996) [Pubmed]
  15. Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Badrising, U.A., Maat-Schieman, M.L., Ferrari, M.D., Zwinderman, A.H., Wessels, J.A., Breedveld, F.C., van Doorn, P.A., van Engelen, B.G., Hoogendijk, J.E., Höweler, C.J., de Jager, A.E., Jennekens, F.G., Koehler, P.J., de Visser, M., Viddeleer, A., Verschuuren, J.J., Wintzen, A.R. Ann. Neurol. (2002) [Pubmed]
  16. Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice. Tamir, S., deRojas-Walker, T., Gal, A., Weller, A.H., Li, X., Fox, J.G., Wogan, G.N., Tannenbaum, S.R. Cancer Res. (1995) [Pubmed]
  17. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P.J., Lee, E., Danning, C., Wada, R., Thompson, C., Bahtiyar, G., Craft, J., Hooft Van Huijsduijnen, R., Plotz, P. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  18. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Wiendl, H., Behrens, L., Maier, S., Johnson, M.A., Weiss, E.H., Hohlfeld, R. Ann. Neurol. (2000) [Pubmed]
  19. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. Sugiura, T., Murakawa, Y., Nagai, A., Kondo, M., Kobayashi, S. Arthritis Rheum. (1999) [Pubmed]
  20. The role of cytokines in polymyositis. III. Recombinant human interferon-gamma enhances T cell adhesion to cultured human muscle cells. Kalovidouris, A.E., Horn, C.A., Plotkin, Z. Arthritis Rheum. (1994) [Pubmed]
  21. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Greenberg, S.A., Pinkus, J.L., Pinkus, G.S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R.J., Saperstein, D.S., Briemberg, H.R., Ericsson, M., Park, P., Amato, A.A. Ann. Neurol. (2005) [Pubmed]
  22. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies. Mirabella, M., Alvarez, R.B., Engel, W.K., Weisgraber, K.H., Askanas, V. Ann. Neurol. (1996) [Pubmed]
  23. Steroid myopathy in connective tissue disease. Askari, A., Vignos, P.J., Moskowitz, R.W. Am. J. Med. (1976) [Pubmed]
  24. Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis. Bassez, G., Authier, F.J., Lechapt-Zalcman, E., Delfau-Larue, M.H., Plonquet, A., Coquet, M., Illa, I., Gherardi, R.K. J. Neuropathol. Exp. Neurol. (2003) [Pubmed]
  25. Intervertebral disk calcification associated with spine fusion. Dussault, R.G., Kaye, J.J. Radiology. (1977) [Pubmed]
  26. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Casciola-Rosen, L.A., Pluta, A.F., Plotz, P.H., Cox, A.E., Morris, S., Wigley, F.M., Petri, M., Gelber, A.C., Rosen, A. Arthritis Rheum. (2001) [Pubmed]
  27. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Murata, K., Dalakas, M.C. Am. J. Pathol. (1999) [Pubmed]
  28. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Gabay, C., Gay-Croisier, F., Roux-Lombard, P., Meyer, O., Maineti, C., Guerne, P.A., Vischer, T., Dayer, J.M. Arthritis Rheum. (1994) [Pubmed]
  29. Cytokine expression profile in idiopathic inflammatory myopathies. Tews, D.S., Goebel, H.H. J. Neuropathol. Exp. Neurol. (1996) [Pubmed]
  30. Differential expression of chemokines in inflammatory myopathies. De Bleecker, J.L., De Paepe, B., Vanwalleghem, I.E., Schröder, J.M. Neurology (2002) [Pubmed]
  31. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. Targoff, I.N., Reichlin, M. J. Immunol. (1987) [Pubmed]
  32. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Hirakata, M., Mimori, T., Akizuki, M., Craft, J., Hardin, J.A., Homma, M. Arthritis Rheum. (1992) [Pubmed]
  33. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Joffe, M.M., Love, L.A., Leff, R.L., Fraser, D.D., Targoff, I.N., Hicks, J.E., Plotz, P.H., Miller, F.W. Am. J. Med. (1993) [Pubmed]
  34. Hereditary complement (C2) deficiency with dermatomyositis. Leddy, J.P., Griggs, R.C., Klemperer, M.R., Frank, M.M. Am. J. Med. (1975) [Pubmed]
WikiGenes - Universities